Molecular-Targeted Therapies for Hematologic Malignancies

por Bunting, Kevin D., Qu, Cheng-Kui, Tomasson, Michael H.
Publicado 2012

Computational Model of Progression to Multiple Myeloma Identifies Optimum Screening Strategies

por Altrock, Philipp M., Ferlic, Jeremy, Galla, Tobias, Tomasson, Michael H., Michor, Franziska
Publicado 2018

Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug delivery

por Pan, Dipanjan, Pham, Christine TN, Weilbaecher, Katherine N, Tomasson, Michael H, Wickline, Samuel A, Lanza, Gregory M
Publicado 2016

Very Late Antigen-4 (α(4)β(1) Integrin) Targeted PET Imaging of Multiple Myeloma

por Soodgupta, Deepti, Hurchla, Michelle A., Jiang, Majiong, Zheleznyak, Alexander, Weilbaecher, Katherine N., Anderson, Carolyn J., Tomasson, Michael H., Shokeen, Monica
Publicado 2013

Correction: Very Late Antigen-4 (α(4)β(1) Integrin) Targeted PET Imaging of Multiple Myeloma

por Soodgupta, Deepti, Hurchla, Michelle A., Jiang, Majiong, Zheleznyak, Alexander, Weilbaecher, Katherine N., Anderson, Carolyn J., Tomasson, Michael H., Shokeen, Monica
Publicado 2013

Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma

por Tomasson, Michael H., Ali, Mahmoud, De Oliveira, Vanessa, Xiao, Qian, Jethava, Yogesh, Zhan, Fenghuang, Fitzsimmons, Adam M., Bates, Melissa L.
Publicado 2018

Germinal Center B-Cells Resist Transformation by Kras Independently of Tumor Suppressor Arf

por Mullins, Chelsea D., Su, Mack Y., Hucthagowder, Vishwanathan, Chu, Liang, Lu, Lan, Kulkarni, Shashikant, Novack, Deborah, Vij, Ravi, Tomasson, Michael H.
Publicado 2013

The snoRNA target of t(4;14) in multiple myeloma regulates ribosome biogenesis

por Oliveira, Vanessa, Mahajan, Nitin, Bates, Melissa L., Tripathi, Chakrapani, Kim, Kyusik Q., Zaher, Hani S., Maggi Jr, Leonard B., Tomasson, Michael H.
Publicado 2019

Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees

por Glenn, Martha J., Madsen, Michael J., Davis, Ethan, Garner, Cassandra D., Curtin, Karen, Jones, Brandt, Williams, Justin A., Tomasson, Michael H., Camp, Nicola J.
Publicado 2019

S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATIO...

por Mohty, Mohamad, Tomasson, Michael H., Arnulf, Bertrand, Bahlis, Nizar J, Rodríguez-Otero, Paula, Martinez-Lopez, Joaquín, Touzeau, Cyrille, Quach, Hang, Depaus, Julien, Yokoyama, Hisayuki, Manier, Salomon, Raje, Noopur, Raab, Marc S., Searle, Emma, Leip, Eric, Sullivan, Sharon T., Czibere, Akos, Viqueira, Andrea, Lesokhin, Alexander
Publicado 2023

Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types

por Amend, Sarah R., Wilson, William C., Chu, Liang, Lu, Lan, Liu, Pengyuan, Serie, Daniel, Su, Xinming, Xu, Yalin, Wang, Dingyan, Gramolini, Anthony, Wen, Xiao-Yan, O’Neal, Julie, Hurchla, Michelle, Vachon, Celine M., Colditz, Graham, Vij, Ravi, Weilbaecher, Katherine N., Tomasson, Michael H.
Publicado 2015

A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5

por White, Brian S., Lanc, Irena, O’Neal, Julie, Gupta, Harshath, Fulton, Robert S., Schmidt, Heather, Fronick, Catrina, Belter, Edward A., Fiala, Mark, King, Justin, Ahmann, Greg J., DeRome, Mary, Mardis, Elaine R., Vij, Ravi, DiPersio, John F., Levy, Joan, Auclair, Daniel, Tomasson, Michael H.
Publicado 2018

Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial

por Bahlis, Nizar J., Costello, Caitlin L., Raje, Noopur S., Levy, Moshe Y., Dholaria, Bhagirathbhai, Solh, Melhem, Tomasson, Michael H., Damore, Michael A., Jiang, Sibo, Basu, Cynthia, Skoura, Athanasia, Chan, Edward M., Trudel, Suzanne, Jakubowiak, Andrzej, Gasparetto, Cristina, Chu, Michael P., Dalovisio, Andrew, Sebag, Michael, Lesokhin, Alexander M.
Publicado 2023

SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution

por Miller, Christopher A., White, Brian S., Dees, Nathan D., Griffith, Malachi, Welch, John S., Griffith, Obi L., Vij, Ravi, Tomasson, Michael H., Graubert, Timothy A., Walter, Matthew J., Ellis, Matthew J., Schierding, William, DiPersio, John F., Ley, Timothy J., Mardis, Elaine R., Wilson, Richard K., Ding, Li
Publicado 2014

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results

por Lesokhin, Alexander M., Tomasson, Michael H., Arnulf, Bertrand, Bahlis, Nizar J., Miles Prince, H., Niesvizky, Ruben, Rodrίguez-Otero, Paula, Martinez-Lopez, Joaquin, Koehne, Guenther, Touzeau, Cyrille, Jethava, Yogesh, Quach, Hang, Depaus, Julien, Yokoyama, Hisayuki, Gabayan, Afshin Eli, Stevens, Don A., Nooka, Ajay K., Manier, Salomon, Raje, Noopur, Iida, Shinsuke, Raab, Marc-Steffen, Searle, Emma, Leip, Eric, Sullivan, Sharon T., Conte, Umberto, Elmeliegy, Mohamed, Czibere, Akos, Viqueira, Andrea, Mohty, Mohamad
Publicado 2023

RECURRENT MUTATIONS IN THE U2AF1 SPLICING FACTOR IN MYELODYSPLASTIC SYNDROMES

por Graubert, Timothy A., Shen, Dong, Ding, Li, Okeyo-Owuor, Theresa, Lunn, Cara L., Shao, Jin, Krysiak, Kilannin, Harris, Christopher C., Koboldt, Daniel C., Larson, David E., McLellan, Michael D., Dooling, David J., Abbott, Rachel M., Fulton, Robert S., Schmidt, Heather, Kalicki-Veizer, Joelle, O’Laughlin, Michelle, Grillot, Marcus, Baty, Jack, Heath, Sharon, Frater, John L., Nasim, Talat, Link, Daniel C., Tomasson, Michael H., Westervelt, Peter, DiPersio, John F., Mardis, Elaine R., Ley, Timothy J., Wilson, Richard K., Walter, Matthew J.
Publicado 2011

Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing

por Ding, Li, Ley, Timothy J., Larson, David E., Miller, Christopher A., Koboldt, Daniel C., Welch, John S., Ritchey, Julie K., Young, Margaret A., Lamprecht, Tamara, McLellan, Michael D., McMichael, Joshua F., Wallis, John W., Lu, Charles, Shen, Dong, Harris, Christopher C., Dooling, David J., Fulton, Robert S., Fulton, Lucinda L., Chen, Ken, Schmidt, Heather, Kalicki-Veizer, Joelle, Magrini, Vincent J., Cook, Lisa, McGrath, Sean D., Vickery, Tammi L., Wendl, Michael C., Heath, Sharon, Watson, Mark A., Link, Daniel C., Tomasson, Michael H., Shannon, William D., Payton, Jacqueline E., Kulkarni, Shashikant, Westervelt, Peter, Walter, Matthew J., Graubert, Timothy A., Mardis, Elaine R., Wilson, Richard K., DiPersio, John F.
Publicado 2012

DNA sequencing of a cytogenetically normal acute myeloid leukemia genome

por Ley, Timothy J, Mardis, Elaine R, Ding, Li, Fulton, Bob, McLellan, Michael D, Chen, Ken, Dooling, David, Dunford-Shore, Brian H, McGrath, Sean, Hickenbotham, Matthew, Cook, Lisa, Abbott, Rachel, Larson, David E, Koboldt, Dan C, Pohl, Craig, Smith, Scott, Hawkins, Amy, Abbott, Scott, Locke, Devin, Hillier, LaDeana W, Miner, Tracie, Fulton, Lucinda, Magrini, Vincent, Wylie, Todd, Glasscock, Jarret, Conyers, Joshua, Sander, Nathan, Shi, Xiaoqi, Osborne, John R, Minx, Patrick, Gordon, David, Chinwalla, Asif, Zhao, Yu, Ries, Rhonda E, Payton, Jacqueline E, Westervelt, Peter, Tomasson, Michael H, Watson, Mark, Baty, Jack, Ivanovich, Jennifer, Heath, Sharon, Shannon, William D, Nagarajan, Rakesh, Walter, Matthew J, Link, Daniel C, Graubert, Timothy A, DiPersio, John F, Wilson, Richard K
Publicado 2008